Please try another search
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
---|---|---|---|---|---|---|---|---|---|
ABN AMRO | 15.44 | 15.71 | 15.16 | +0.35 | +2.29% | 4.06M | 02/05 | ||
Aegon | 5.858 | 5.930 | 5.846 | +0.002 | +0.03% | 5.37M | 02/05 | ||
Allfunds Group | 5.88 | 5.99 | 5.83 | -0.07 | -1.09% | 1.01M | 02/05 | ||
ASR Nederland | 46.66 | 47.21 | 46.62 | -0.31 | -0.66% | 387.05K | 02/05 | ||
BM3EAC | 10.00 | 10.00 | 10.00 | 0.00 | 0.00% | 0 | 01/01 | ||
Boussard Gavaudan | 26.00 | 26.00 | 26.00 | 0.00 | 0.00% | 0.50K | 02/05 | ||
Eurocastle Investment | 7.30 | 7.30 | 7.30 | +0.00 | +0.00% | 0 | 30/04 | ||
Euronext | 84.65 | 85.05 | 84.40 | 0.00 | 0.00% | 121.89K | 02/05 | ||
European Healthcare Acquisition Growth BV | 9.15 | 9.15 | 9.15 | 0.00 | 0.00% | 0 | 12/04 | ||
Exor NV | 102.60 | 103.20 | 100.70 | -0.10 | -0.10% | 202.27K | 02/05 | ||
Flow Traders NV | 19.49 | 19.76 | 19.35 | +0.20 | +1.04% | 242.81K | 02/05 | ||
Hal Trust | 119.60 | 123.40 | 119.60 | -4.40 | -3.55% | 48.37K | 02/05 | ||
ING Groep | 15.81 | 16.04 | 15.21 | +0.95 | +6.37% | 25.47M | 02/05 | ||
Iris Financial | 0.00 | 0.00 | 0.00 | 0.00 | 0.00% | 0 | 01/01 | ||
New Amsterdam Invest NV | 8.70 | 8.85 | 8.70 | 0.00 | 0.00% | 0 | 29/04 | ||
NN Group NV | 43.12 | 43.67 | 43.03 | -0.23 | -0.53% | 679.34K | 02/05 | ||
Pershing Square | 50.10 | 50.50 | 49.70 | +0.90 | +1.83% | 20.45K | 02/05 | ||
Tetragon | 9.70 | 9.70 | 9.62 | -0.06 | -0.61% | 5.91K | 02/05 | ||
Value8 | 5.80 | 5.80 | 5.75 | 0.00 | 0.00% | 2.92K | 02/05 | ||
Van Lanschot | 34.70 | 34.70 | 33.35 | +1.35 | +4.05% | 145.92K | 02/05 | ||
Volta Finance | 5.15 | 5.15 | 5.15 | 0.00 | 0.00% | 22.20K | 02/05 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review